Michael Cherny
Stock Analyst at Leerink Partners
(4.01)
# 1,652
Out of 4,402 analysts
553
Total ratings
55.2%
Success rate
4.7%
Average return
Main Sectors:
Stocks Rated by Michael Cherny
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Maintained: Hold | $125 → $145 | $144.59 | +0.28% | 17 | May 28, 2026 | |
| ALGN Align Technology | Maintained: Buy | $172 → $230 | $170.50 | +34.90% | 19 | May 27, 2026 | |
| DOCS Doximity | Rated: Buy | $79 → $25 | $20.24 | +23.52% | 14 | May 15, 2026 | |
| MDLN Medline | Maintained: Buy | $56 | $36.54 | +53.26% | 3 | Apr 24, 2026 | |
| HIMS Hims & Hers Health | Maintained: Hold | n/a | $27.78 | - | 32 | Apr 16, 2026 | |
| CVS CVS Health | Reiterated: Buy | $98 | $98.02 | -0.02% | 66 | Mar 24, 2026 | |
| HSIC Henry Schein | Reiterated: Hold | $87 | $78.85 | +10.34% | 31 | Feb 24, 2026 | |
| NVST Envista Holdings | Upgraded: Buy | $35 | $24.06 | +45.47% | 24 | Feb 6, 2026 | |
| WAY Waystar Holding | Initiated Coverage: Buy | $43 | $18.80 | +128.72% | 1 | Feb 2, 2026 | |
| CAH Cardinal Health | Reiterated: Buy | $187 → $240 | $216.30 | +10.96% | 38 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $13 | $5.18 | +150.97% | 15 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $232 → $256 | $182.17 | +40.53% | 16 | Dec 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $203 → $210 | $203.78 | +3.05% | 18 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 | $10.04 | +34.46% | 33 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5 → $6 | $2.74 | +118.98% | 21 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $323 → $342 | $268.63 | +27.31% | 14 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $455 → $490 | $465.73 | +5.21% | 6 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $349 → $361 | $281.24 | +28.36% | 37 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $790.44 | - | 45 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.56 | - | 23 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $25.89 | - | 35 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7.5 | $7.03 | +6.69% | 19 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $542 | $435.71 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $45.06 | n/a | 1 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.21 | n/a | 1 | Jul 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $5.10 | n/a | 16 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $11 | $0.2887 | n/a | 6 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7.5 | $8.42 | n/a | 1 | Jan 5, 2022 |
ICON Public Limited Company
May 28, 2026
Maintained: Hold
Price Target: $125 → $145
Current: $144.59
Upside: +0.28%
Align Technology
May 27, 2026
Maintained: Buy
Price Target: $172 → $230
Current: $170.50
Upside: +34.90%
Doximity
May 15, 2026
Rated: Buy
Price Target: $79 → $25
Current: $20.24
Upside: +23.52%
Medline
Apr 24, 2026
Maintained: Buy
Price Target: $56
Current: $36.54
Upside: +53.26%
Hims & Hers Health
Apr 16, 2026
Maintained: Hold
Price Target: n/a
Current: $27.78
Upside: -
CVS Health
Mar 24, 2026
Reiterated: Buy
Price Target: $98
Current: $98.02
Upside: -0.02%
Henry Schein
Feb 24, 2026
Reiterated: Hold
Price Target: $87
Current: $78.85
Upside: +10.34%
Envista Holdings
Feb 6, 2026
Upgraded: Buy
Price Target: $35
Current: $24.06
Upside: +45.47%
Waystar Holding
Feb 2, 2026
Initiated Coverage: Buy
Price Target: $43
Current: $18.80
Upside: +128.72%
Cardinal Health
Jan 13, 2026
Reiterated: Buy
Price Target: $187 → $240
Current: $216.30
Upside: +10.96%
Jan 6, 2026
Upgraded: Buy
Price Target: $13
Current: $5.18
Upside: +150.97%
Dec 14, 2025
Maintained: Buy
Price Target: $232 → $256
Current: $182.17
Upside: +40.53%
Oct 22, 2025
Reiterated: Buy
Price Target: $203 → $210
Current: $203.78
Upside: +3.05%
Oct 14, 2025
Maintained: Hold
Price Target: $14
Current: $10.04
Upside: +34.46%
Oct 9, 2025
Rated: Hold
Price Target: $5 → $6
Current: $2.74
Upside: +118.98%
Oct 8, 2025
Reiterated: Buy
Price Target: $323 → $342
Current: $268.63
Upside: +27.31%
Oct 8, 2025
Reiterated: Hold
Price Target: $455 → $490
Current: $465.73
Upside: +5.21%
Oct 6, 2025
Maintained: Buy
Price Target: $349 → $361
Current: $281.24
Upside: +28.36%
Oct 6, 2025
Maintained: Buy
Price Target: n/a
Current: $790.44
Upside: -
Oct 2, 2025
Reiterated: Buy
Price Target: n/a
Current: $2.56
Upside: -
Oct 1, 2025
Reiterated: Buy
Price Target: n/a
Current: $25.89
Upside: -
Jul 30, 2025
Reiterated: Hold
Price Target: $7.5
Current: $7.03
Upside: +6.69%
Dec 20, 2024
Reiterated: Buy
Price Target: $542
Current: $435.71
Upside: n/a
Sep 4, 2024
Maintained: Hold
Price Target: n/a
Current: $45.06
Upside: n/a
Jul 8, 2024
Reiterated: Buy
Price Target: n/a
Current: $1.21
Upside: n/a
Jun 14, 2023
Maintained: Buy
Price Target: $22
Current: $5.10
Upside: n/a
May 11, 2023
Maintained: Sell
Price Target: $11
Current: $0.2887
Upside: n/a
Jan 5, 2022
Maintained: Hold
Price Target: $7.5
Current: $8.42
Upside: n/a